Symptomatic HIV seroconverting illness is associated with more rapid neurological impairment.

OBJECTIVES

To establish whether symptomatic seroconverting illness in HIV infected people is associated with more rapid development of neurological impairment.

METHODS

166 HIV infected subjects with a known date of HIV infection enrolled in a longitudinal study of neurocognitive function were stratified by whether or not they had experienced a symptomatic serconverting illness.

RESULTS

29 of 166 (17.5%) dated HIV seroconverters had a history of symptomatic seroconverting illness. Though baseline neurocognitive function was similar, subjects with a symptomatic seroconverting illness developed clinical neurocognitive impairment significantly more rapidly than their asymptomatic counterparts in a survival analysis model (636 v 1075 days till impaired).

CONCLUSION

Symptomatic seroconverting illness predisposes to more rapid neurocognitive impairment.